The Genomics of Drug Sensitivity in Cancer project is an academic research program to identify molecular features of cancers that predict response to anti-cancer drugs.

Browse our data

Please be aware that our website and results are part of an ongoing project. These webpages are updated frequently and our results are not final or complete.


e.g. Docetaxel, RP-56976, BRAF, COLO-829

What's new!

  • Release 4 (March 2013)
  • This release features improvements increasing the functionality of the GDSC website to facilitate analysis and interpretation of results.

More information

Mailing List

To receive news and data release alert, please sign up Translation-announce

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Trust Sanger Institute.